XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.23.1

Segment Information | 9 Months Ended
--- | ---
Mar. 31, 2023
Notes to Financial Statements |
Segment Information | Note 13. Segment Information: The Company's management evaluates segment operating performance based on operating income before certain charges to cost of sales and selling, general and administrative expenses, principally associated with the impact of partially-owned consolidated subsidiaries as well as acquisition accounting related to inventory, amortization of acquisition-related intangible assets and other acquisition-related expenses. The Protein Sciences and Diagnostics and Genomics segments both include consumables, instruments, services and royalty revenue. The following is financial information relating to the Company's reportable segments (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Quarter Ended | ​ | Nine Months Ended
​ | ​ | March 31, | ​ | March 31,
​ |  | 2023 |  | 2022 | ​ | 2023 |  | 2022
Net sales: |  | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​
Protein Sciences | ​ | $ | 218,903 |  | $ | 213,176 | ​ | $ | 622,739 |  | $ | 615,332
Diagnostics and Genomics | ​ |  | 75,669 | ​ |  | 77,679 | ​ |  | 213,577 | ​ |  | 203,191
Intersegment | ​ |  | (426) | ​ |  | (479) | ​ |  | (934) | ​ |  | (1,152)
Consolidated net sales | ​ | $ | 294,146 |  | $ | 290,376 | ​ | $ | 835,382 |  | $ | 817,371
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating income: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Protein Sciences | ​ | $ | 98,756 |  | $ | 96,750 | ​ | $ | 274,035 |  | $ | 280,131
Diagnostics and Genomics | ​ |  | 11,464 | ​ |  | 19,405 | ​ |  | 28,399 | ​ |  | 37,748
Segment operating income | ​ | $ | 110,220 | ​ | $ | 116,155 | ​ | $ | 302,434 | ​ | $ | 317,879
Costs recognized on sale of acquired inventory | ​ |  | — | ​ |  | — | ​ |  | (400) | ​ |  | (1,596)
Amortization of acquisition related intangible assets | ​ |  | (19,286) | ​ |  | (18,173) | ​ |  | (57,694) | ​ |  | (54,942)
Impact of partially-owned consolidated subsidiaries(1) | ​ |  | — | ​ |  | (892) | ​ |  | 647 | ​ |  | (3,446)
Acquisition related expenses and other | ​ |  | 1,333 | ​ |  | 3,710 | ​ |  | 9,343 | ​ |  | 19,328
Eminence impairment | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (18,715)
Stock based compensation, inclusive of employer taxes | ​ |  | (10,543) | ​ |  | (9,056) | ​ |  | (42,879) | ​ |  | (37,731)
Restructuring costs | ​ |  | — | ​ |  | 291 | ​ |  | (2,950) | ​ |  | (1,638)
Corporate general, selling, and administrative expenses | ​ |  | (1,513) | ​ |  | (1,588) | ​ |  | (4,082) | ​ |  | (3,122)
Consolidated operating income | ​ | $ | 80,211 |  | $ | 90,447 | ​ | $ | 204,419 |  | $ | 216,017
​ (1) Includes the quarterly results of the partially-owned consolidated subsidiary prior to the sale of this partially-owned consolidated subsidiary to a third party in the first fiscal quarter of 2023.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI https://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration